Compugen Share Price

Compugen Share Price

NASDAQ: CGEN | Healthcare
$2.02
-$0.01 (-0.74%) Last updated on 19 Nov, 2026 | 01:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Compugen Stock Performance

Open
$2.01
Prev. Close
$2.03
Circuit Range
N/A
Day Range
$1.99 - $2.02
Year Range
$1.44 - $3.23
Volume
3,648
Average Traded
$2.01

Compugen Share Price Today

As of 19 November 2026, Compugen Ltd.'s share price is $2.02. The stock opened at $2.01, compared to its previous close of $2.03. During today's trading session, Compugen Ltd.'s share price traded between $1.99 and $2.02, with an average price of $2.00. Over the past 52 weeks, the stock has recorded a high of $3.23 and a low of $1.44. In terms of performance, Compugen Ltd.'s share price has declined by 23.67% over the last six months and is up 29.17% on a year-on-year basis.

Compugen Share Price Chart

Line chart of the Compugen price trend over the selected period. The price fell overall, ranging from 1.99 to 2.02, ending at 2.02.
$1.99$2.02
L
Show Current Price
H

Compugen Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$72.76B
Return On Equity (TTM)
N/A
Profit Margin
48.57%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Compugen Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$7.50$33.46$27.86$72.76
Net Profit-$33.69-$18.75-$14.23$35.34
Net Profit Margin-449.20%-56.04%-51.08%48.57%
Income ChangeN/A44.35%24.11%348.35%

Compugen Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets8.559.06.768.05
Current Assets148.02106.0114.5886.13
Total Assets156.57115.0121.3394.18
Non Current Liabilities31.2739.9229.514.58
Current Liabilities22.5720.1626.2711.92
Total Liabilities53.8460.0855.7816.5
Shareholders' Equity102.7354.9165.5677.68

Compugen Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating31.6349.6-35.89-34.11
Investing30.0-46.2535.5137.06
Financing10.60.553.080.35

About Compugen

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Compugen Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.98
$2.01
+1.21%
Oct 2026
$2.44
$1.99
-16.95%
Sep 2026
$2.56
$2.39
-13.09%
Aug 2026
$2.30
$2.75
+16.53%
Jul 2026
$2.17
$2.36
+10.28%
Jun 2026
$2.54
$2.14
-18.94%
May 2026
$2.69
$2.64
-0.75%
Apr 2026
$2.19
$2.66
+25.47%
Mar 2026
$1.91
$2.12
+17.13%
Feb 2026
$1.85
$1.81
-1.63%
Jan 2026
$1.57
$1.84
+20.26%
Dec 2025
$1.56
$1.53
-1.92%

Compugen Share Price FAQs